Prognostic markers in node-negative brea
β
Kute, T. E. ;Russell, G. B. ;Zbieranski, N. ;Long, R. ;Johnston, S. ;Williams, H
π
Article
π
2004
π
John Wiley and Sons
π
English
β 126 KB
## Abstract ## Background Despite years of research, it is still unclear which women with nodeβnegative (Nβ) breast cancer will need adjuvant chemotherapy and which women are being treated unnecessarily. Our goal was to determine which factors best predicted disease free survival (DFS) or cancerβs